Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
International Reviews of Immunology|January 1, 1997
Human IgG Fc receptorsI A Heijnen, J G van de WinkelJournal of Hematotherapy|October 1, 1995
A human Fc gamma RI/CD64 transgenic model for in vivo analysis of (bispecific) antibody therapeuticsI A Heijnen, J G Van de WinkelCancer Immunology, Immunotherapy : CII|January 22, 1998
Lysis of murine B lymphoma cells by transgenic phagocytes via a human Fc gamma RI x murine MHC class II bispecific antibodyI A Heijnen, M J Glennie, J G van de WinkelBlood|November 9, 2000
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphomaJ Honeychurch, A L Tutt, T Valerius, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 1998
Mice lacking IL-12 develop polarized Th1 cells during viral infectionV E Schijns, B L Haagmans, C M Wierda, et al.Cancer Research|December 3, 1999
Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodiesG Huls, I A Heijnen, E Cuomo, et al.Cancer Research|February 15, 1997
Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancerB Stockmeyer, T Valerius, R Repp, et al.Blood|May 1, 1996
FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivoM J van Vugt, I A Heijnen, P J Capel, et al.Immunity|August 1, 1996
Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient miceW L Hazenbos, J E Gessner, F M Hofhuis, et al.The Journal of Clinical Investigation|January 15, 1996
Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic miceI A Heijnen, M J van Vugt, N A Fanger, et al.Pageof 2